(Hypertension. 1997;29:8.)
© 1997 American Heart Association, Inc.
Research Articles (Issue 1, Part 1) |
Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women
Treatment of Mild Hypertension Study (TOMHS)
the Shapiro Center for Evidence-Based Medicine, Minneapolis Medical Research Foundation, and Division of Clinical Epidemiology, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minn (R.H.G.); Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis (G.A.G., K.S.); Department of Epidemiology and Public Health, University of Miami (Fla), School of Medicine (R.J.P.); Department of Medicine, University of Pittsburgh (Pa) (R.H.M.); Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham (C.E.L.); Hypertension Center, The Bowman-Gray School of Medicine at Wake Forest University, Winston-Salem, NC (J.M.F., C.Y.); Section of Cardiology, Department of Medicine, and Department of Preventive Medicine, Rush Medical Center, Chicago, Ill (P.R.L.); Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (P.J.E.); and Department of Preventive Medicine, Northwestern University Medical School, Chicago, Ill (J.S.).
Problems with sexual function have been a long-standing concern in the treatment of hypertension and may influence the choice of treatment regimens and decisions to discontinue drugs. The Treatment of Mild Hypertension Study (TOMHS) provides an excellent opportunity for examination of sexual function and effects of treatment on sexual function in men and women with stage I diastolic hypertension because of the number of drug classes studied, the double-blind study design, and the long-term follow-up. TOMHS was a double-blind, randomized controlled trial of 902 hypertensive individuals (557 men, 345 women), aged 45 to 69 years, treated with placebo or one of five active drugs (acebutolol, amlodipine maleate, chlorthalidone, doxazosin maleate, or enalapril maleate). All participants received intensive lifestyle counseling regarding weight loss, dietary sodium reduction, alcohol reduction (for current drinkers), and increased physical activity. Sexual function was ascertained by physician interviews at baseline and annually during follow-up. At baseline, 14.4% of men and 4.9% of women reported problems with sexual function. In men, 12.2% had problems obtaining and/or maintaining an erection; 2.0% of women reported a problem having an orgasm. Erection problems in men at baseline were positively related to age, systolic pressure, and previous antihypertensive drug use. The incidences of erection dysfunction during follow-up in men were 9.5% and 14.7% through 24 and 48 months, respectively, and were related to type of antihypertensive therapy. Participants randomized to chlorthalidone reported a significantly higher incidence of erection problems through 24 months than participants randomized to placebo (17.1% versus 8.1%, P=.025). Incidence rates through 48 months were more similar among treatment groups than at 24 months, with nonsignificant differences between the chlorthalidone and placebo groups. Incidence was lowest in the doxazosin group but was not significantly different from the placebo group. Incidence for acebutolol, amlodipine, and enalapril groups was similar to that in the placebo group. In many cases, erection dysfunction did not require withdrawal of medication. Disappearance of erection problems among men with problems at baseline was common in all groups but greatest in the doxazosin group. Incidence of reported sexual problems in women was low in all treatment groups. In conclusion, long-term incidence of erection problems in treated hypertensive men is relatively low but is higher with chlorthalidone treatment. Effects of erection dysfunction with chlorthalidone appear relatively early and are often tolerable, and new occurrences after 2 years are unlikely. The rate of reported sexual problems in hypertensive women is low and does not appear to differ by type of drug. Similar incidence rates of erection dysfunction in placebo and most active drug groups caution against routine attribution of erection problems to antihypertensive medication.
Key Words: sexual dysfunction • antihypertensive agents • impotence
This article has been cited by other articles:
 |
|
 |
|
  M R Law, J K Morris, and N J Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ, May 19, 2009; 338(may19_1): b1665 - b1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Cooper A 41-Year-Old African American Man With Poorly Controlled Hypertension: Review of Patient and Physician Factors Related to Hypertension Treatment Adherence JAMA, March 25, 2009; 301(12): 1260 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Erdmann Safety and tolerability of beta-blockers: prejudices and reality Eur. Heart J. Suppl., March 1, 2009; 11(suppl_A): A21 - A25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Baumhakel, N. Schlimmer, K. Buyukafsar, O. Arikan, and M. Bohm Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 818 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Os, V. Franco, S. E. Kjeldsen, K. Manhem, R. B. Devereux, E. Gerdts, D. A. Hille, P. A. Lyle, P. M. Okin, B. Dahlof, et al. Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy: Results From the Losartan Intervention For Endpoint Reduction in Hypertension Study Hypertension, April 1, 2008; 51(4): 1103 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Falkensammer, A. G. Hakaim, C. E. Falkensammer, G. A. Broderick, J. E. Crook, M. G. Heckman, W. A. Oldenburg, and B. Hugl Prevalence of erectile dysfunction in vascular surgery patients Vascular Medicine, February 1, 2007; 12(1): 17 - 22. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Baumhakel, N. Werner, M. Bohm, and G. Nickenig Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease Eur. Heart J., September 2, 2006; 27(18): 2184 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Doumas, A. Tsakiris, S. Douma, A. Grigorakis, A. Papadopoulos, A. Hounta, S. Tsiodras, D. Dimitriou, and H. Giamarellou Factors Affecting the Increased Prevalence of Erectile Dysfunction in Greek Hypertensive Compared With Normotensive Subjects J Androl, May 1, 2006; 27(3): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Papatsoris and P. G. Korantzopoulos Hypertension, Antihypertensive Therapy, and Erectile Dysfunction Angiology, January 1, 2006; 57(1): 47 - 52. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Morganti Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No J. Am. Soc. Nephrol., March 1, 2005; 16(3_suppl_1): S70 - S73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Carson Erectile Dysfunction: Evaluation and New Treatment Options Psychosom Med, September 1, 2004; 66(5): 664 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Schiff and J. P. Mulhall The Link Between LUTS and ED: Clinical and Basic Science Evidence J Androl, July 1, 2004; 25(4): 470 - 478. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Fung, R. Bettencourt, and E. Barrett-Connor Heart disease risk factors predict erectile dysfunction 25 years later: The Rancho Bernardo Study J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1405 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular diseases: (1) heart failure Postgrad. Med. J., April 1, 2004; 80(942): 201 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Samson Hypertension and the Vascular Patient Vascular and Endovascular Surgery, March 1, 2004; 38(2): 103 - 119. [Abstract] [PDF]
|
|
|
|
|
|
A. V. Chobanian, G. L. Bakris, H. R. Black, W. C. Cushman, L. A. Green, J. L. Izzo Jr, D. W. Jones, B. J. Materson, S. Oparil, J. T. Wright Jr, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension, December 1, 2003; 42(6): 1206 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Law, N J Wald, J K Morris, and R E Jordan Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials BMJ, June 25, 2003; 326(7404): 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Behr-Roussel, P. Chamiot-Clerc, J. Bernabe, K. Mevel, L. Alexandre, M. E. Safar, and F. Giuliano Erectile dysfunction in spontaneously hypertensive rats: pathophysiological mechanisms Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R682 - R688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Ko, P. R. Hebert, C. S. Coffey, A. Sedrakyan, J. P. Curtis, and H. M. Krumholz {beta}-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction JAMA, July 17, 2002; 288(3): 351 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Alexander Erectile dysfunction The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 244 - 246. [PDF]
|
|
|
|
|
|
H. R. Black, W. J. Elliott, J. D. Neaton, G. Grandits, P. Grambsch, R. H. Grimm Jr, L. Hansson, Y. Lacouciere, J. Muller, P. Sleight, et al. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial Hypertension, January 1, 2001; 37(1): 12 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Opie First line drugs in chronic stable effort angina--the case for newer, longer-acting calcium channel blocking agents J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1967 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sironi, D. Colombo, E. Poggesi, A. Leonardi, R. Testa, O. Rampin, J. Bernabé, and F. Giuliano Effects of Intracavernous Administration of Selective Antagonists of alpha 1-Adrenoceptor Subtypes on Erection in Anesthetized Rats and Dogs J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 974 - 981. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. August Hypertension in Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3451 - 3454. [Full Text] [PDF]
|
|
|
|
|
|
S. Oparil A 42-Year-Old Man With Hypertension JAMA, September 24, 1997; 278(12): 1015 - 1021. [Abstract] [PDF]
|
|